openPR Logo
Press release

Early toxicity testing market is projected to reach $1,301 million by 2025, with a growing CAGR of 7.3%.

06-19-2019 08:22 PM CET | Health & Medicine

Press release from: Allied Market Research

Early Toxicity Testing Market

Early Toxicity Testing Market

The global Early Toxicity Testing Market was pegged at $614 million in 2015 and is projected to reach $1,012 million by 2022, registering a CAGR of 7.3% during the period 2016–2022.

Download the Sample Report @ http://bit.ly/2MZKCp5

Rise in adoption of early toxicity to reduce drug failure in later stages, frequent replacement of in vivo models by in vitro model, and increase in stringent policies of regulatory authorities concerning public health welfare have boosted the growth of the early toxicity testing market. However, limited awareness regarding the benefits of early toxicity testing and limitation of preclinical testing hamper market growth. On the contrary, rapid advancements in in silico platforms and in vitro models are expected to create lucrative opportunities in the near future.

The report splits into technique, end users, and geography. On the basis of technique, the report divides into in vivo, in vitro, and in silico. Moreover, the in vitro technique is further segmented into enzyme toxicity assays, bacterial toxicity assays, cell-based ELISA and western blots, tissues culture assays, receptor binding assays, and other assays. The in vivo segment dominated the market in 2015 and is expected to continue its dominance throughout the study period.

Based on end users, the report bifurcates into the pharmaceuticals industry, diagnostics industry, food industry, chemicals industry, cosmetics industry, and other industries. The pharmaceutical industry is expected to manifest the fastest CAGR by 2022 and projected to hold the largest share in 2022, contributing about two-thirds of the total market. This is attributed to rise in number of clinical trials for drug development. However, the cosmetic industry is projected to portray a CAGR of 9.8% during the study period.

For More Inquiry @ http://bit.ly/2x5KKsq

The report is segmented according to region into Asia-Pacific, North America, Europe, and LAMEA. Europe held the largest market share and is expected to manifest CAGR of 6.6% through 2022. However, China is the fastest growing country in the Asia-Pacific region, with a CAGR of 15.8% during the forecast period.

The report analyzes the leading market players including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Merck & Co., Inc., Becton, Danaher Corporation, The Jackson Laboratory, Bio-Rad Laboratories, Inc., Quest Diagnostics Incorporation, Charles River Laboratories International Incorporation, Dickinson And Company, and Evotec Ag.

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Early toxicity testing market is projected to reach $1,301 million by 2025, with a growing CAGR of 7.3%. here

News-ID: 1781626 • Views: 467

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Early

12-11-2018 | Health & Medicine
DST
New App detects dementia risks early
• The App is certified as a Medical Device. • Early stages are reliably detected, before the brain damage becomes irreversible. • Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%). • Now available for free during pre-launch. Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia. Therefore, effective screening tests are needed to detect early stages
Ethereum Sweepstakes Early Bird Draw Deadline Approaching
Ethereum Sweepstakes the first Blockchain Sweepstakes offering a potential Jackpot worth $1,000,000,000. Ethereum Sweepstakes uses a smart contract and the blockchain to guarantee fair play and guaranteed winners. London, England, April 25, 2018 -- Ethereum Sweepstakes Early Bird draw on May 1 is fast approaching. Don’t miss out on this bonus opportunity to win 20 Ether with a current estimated value of almost $13,000. This bonus draw is in addition to monthly bonus
ELSE Corp startup rated by Early Metrics
The first startup from Italy to receive an official rating, from Early Metrics Milan, May 19, 2017: ELSE Corp, a virtual retail company based in Milan, is proud to announce that they are the first startup from Italy to have been certified by Early Metrics, a rating agency for startups and innovative SMEs from the UK, bringing an objective methodology to assessing a startup's potential growth. Instead of rating a company’s credit risk,
iPad 3 launch anticipated early this March
It’s quite likely that the much awaited iPad 3 will make its debut in March this year. Apple follows a fairly strict schedule for updating its products. The first generation of iPad was launched in March 2010. A year later, iPad 2 made its debut on Wednesday 2nd March. If the rumor mill is to be believed, iPad 3 will be launched on 7th March this year, which is again
Early Morning Smokers Face Higher Cancer Risk
American smokers who light their first cigarette soon after waking up may be at greater risk for lung, head and neck cancers a new study finds. "First thing in the morning smokers face a greater risk according to new research," explains Jesse Slome, executive director of the QAmerican Association for Critical Illness Insurance http://www.criticalillnessinsuranceinfo.org, a trade group. "Those who wait longer before having their first cigarette apparently face a lower
Apron Point Provides Early Christmas Sale
Apron Point, an online shop that specializes in high quality aprons, remains true to its commitment of providing customers value for their money as they launch today an early Christmas sale on their products. Apron Point believes that in the world where customers have plenty of choices to select from, one must be able to provide products that are not only of superior quality but also affordable in price.